Peptonic Medical AB (28L) Stock Price & News

All values in SEK	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	2.58M	3.54M	3.14M	2.36M
Cost of goods sold	1.44M	1.37M	1.02M	945.00K
Cost of revenue	1.44M	1.37M	1.02M	945.00K
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	9.28M	10.07M	6.18M	4.12M
Operating expense	10.64M	1.17M	7.45M	5.63M
Total operating expenses	12.08M	2.54M	8.47M	6.58M
Operating income	-9.50M	998.00K	-5.33M	-4.22M
Other non operating income	-102.00K	1.00K	1.00K	17.00K
EBT including unusual items	-11.24M	-245.00K	-5.68M	-3.84M
EBT excluding unusual items	-11.24M	-245.00K	-5.68M	-4.33M
Income tax expense	-	-	-	-
Effective tax rate	-	-	-	-
Other operating expenses	-90.00K	-10.33M	-166.00K	78.00K
Net income	-11.24M	-245.00K	-5.68M	-3.84M
Net profit margin	-435.50%	-6.92%	-181.13%	-162.58%
Earnings per share	-	-	-	-
Interest and investment income	-	16.00K	64.00K	68.00K
Interest expense	-1.64M	-1.26M	-419.00K	-194.00K
Net interest expenses	-1.64M	-1.24M	-355.00K	-126.00K
Depreciation and amortization charges	1.44M	1.43M	1.44M	1.44M
EBITDA	-9.01M	1.48M	-4.85M	-3.74M
Gain or loss from assets sale	-	-	-	-

Finance